Your browser doesn't support javascript.
loading
COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis?
Akande, Oluwatosin Wuraola; Igumbor, Ehimario Uche; Elimian, Kelly Osezele; Ohonsi, Cornelius Ehizokhai; Nwozor, Lilian; Oden, Okanke; Ekpenyong, Emmanuel Nsa; Ndodo, Nnaemeka; Ike, Ifeanyi F; Egede, Magdalene; Nwachukwu, William; Onoja, Amedu M; Fofah, Jenson Gawain; Azi, Reuben Ishiaku; Ochu, Chinwe L; Adetifa, Ifedayo M.
Afiliação
  • Akande OW; Nigeria Centre for Disease Control (NCDC), Abuja, Nigeria.
  • Igumbor EU; Nigeria COVID-19 Research Coalition (NCRC), Abuja, Nigeria.
  • Elimian KO; Nigeria Centre for Disease Control (NCDC), Abuja, Nigeria.
  • Ohonsi CE; Nigeria COVID-19 Research Coalition (NCRC), Abuja, Nigeria.
  • Nwozor L; School of Public Health, University of the Western Cape, Cape Town, South Africa.
  • Oden O; Nigeria Centre for Disease Control (NCDC), Abuja, Nigeria.
  • Ekpenyong EN; Nigeria COVID-19 Research Coalition (NCRC), Abuja, Nigeria.
  • Ndodo N; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
  • Ike IF; Nigeria Centre for Disease Control (NCDC), Abuja, Nigeria.
  • Egede M; Nigeria COVID-19 Research Coalition (NCRC), Abuja, Nigeria.
  • Nwachukwu W; Nigeria Centre for Disease Control (NCDC), Abuja, Nigeria.
  • Onoja AM; Nigeria COVID-19 Research Coalition (NCRC), Abuja, Nigeria.
  • Fofah JG; Nigeria Centre for Disease Control (NCDC), Abuja, Nigeria.
  • Azi RI; Nigeria COVID-19 Research Coalition (NCRC), Abuja, Nigeria.
  • Ochu CL; Nigeria COVID-19 Research Coalition (NCRC), Abuja, Nigeria.
  • Adetifa IM; Nigeria Centre for Disease Control (NCDC), Abuja, Nigeria.
J Glob Health ; 12: 03055, 2022 08 03.
Article em En | MEDLINE | ID: mdl-35916589

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans País/Região como assunto: Africa Idioma: En Revista: J Glob Health Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Nigéria

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans País/Região como assunto: Africa Idioma: En Revista: J Glob Health Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Nigéria